Send Message
801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsOral Medications

Stomach Ulcers Oral Medications Omeprazole Enteric Coated Tablets 10mg - 40mg

Stomach Ulcers Oral Medications Omeprazole Enteric Coated Tablets 10mg - 40mg

  • Stomach Ulcers Oral Medications Omeprazole Enteric Coated Tablets 10mg - 40mg
Stomach Ulcers Oral Medications Omeprazole Enteric Coated Tablets 10mg - 40mg
Product Details:
Place of Origin: China
Brand Name: Newlystar
Certification: GMP
Model Number: 10mg, 20mg, 40mg
Payment & Shipping Terms:
Minimum Order Quantity: two million capsules
Price: Negotiation
Packaging Details: 7’s/blister
Delivery Time: 45days
Payment Terms: L/C, T/T
Supply Ability: one million pills per day
Contact Now
Detailed Product Description
Product: Omeprazole Enteric-coated Tablets Capsules Specification: 10mg, 20mg, 40mg
Standard: BP, USP Packing: 7’s/blister
High Light:

oral treatment

,

oral preparation

Stomach Ulcers Oral Medications Omeprazole Enteric Coated Tablets 10mg - 40mg

 

 

Product : Omeprazole Enteric-coated Tablets Capsules

Specification : 10mg, 20mg, 40mg

Standard : BP, USP

Packing : 7’s/blister

 

Description :

Omeprazole is a highly effective inhibitor of gastric acid secretion used in the therapy of stomach ulcers and Zollinger-Ellison syndrome. Omeprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell.

 

Indication

Omeprazole is indicated for the treatment of duodenal ulcers, benign gastric ulcers, gastroesophageal reflux disease (GERD), heartburn and other symptoms associated with GERD, erosive esophagitis, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison syndrome, multiple endocrine adenomas, and systemic mastocytosis.

 

Pharmacodynamics

After oral administration, the onset of the anti-secretory effect of omeprazole occurs within one hour and maximum effect occurring within two hours. At 24 hours, inhibition of secretion is approximately 50% of maximum and duration of inhibition lasts up to 72 hours. Although omeprazole has a very short plasma half-life, the anti-secretory effect lasts for a long time due to prolonged binding to parietal H+/K+ ATPase enzyme. When the drug has been discontinued, secretory activity will return to baseline over 3-5 days. The inhibitory effect of omeprazole on acid secretion increases with repeated once-daily dosing, reaching a plateau after four days. In studies involving more than 200 patients, serum gastrin levels increased during the first 1 to 2 weeks of once-daily administration of therapeutic doses of omeprazole in parallel with inhibition of acid secretion. Systemic effects of omeprazole in the CNS, cardiovascular and respiratory systems have not been found to date.

 

Mechanism of action

Omeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. By acting specifically on the proton pump, omeprazole blocks the final step in acid production, thus reducing gastric acidity.

Contact Details
Newlystar (Ningbo) Medtech Co.,Ltd.

Contact Person: Mr. Luke Liu

Tel: 86--57487019333

Fax: 86-574-8701-9298

Send your inquiry directly to us (0 / 3000)

Other Products